CELL SURVIVAL PATHWAYS
CELL SURVIVAL PATHWAYS
批准号:
6390192
负责人:
Stephen MARK Schwartz
金额:
$32.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2002-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The rupture of the fibrous cap is the critical event leading to
thromboembolic complications on the luminal surface of advanced
atherosclerotic plaques. The factors that set the stage for plaque
disruption include progressive cap atrophy with loss of cells and
matrix. Unfortunately, these beliefs are hard to test because of a lack
of animal models. We propose to solve this problem by an
interdisciplinary approach combining human tissue and animal model
studies of molecular pathways that could underlie this process. In
Grant 1 (T. Hatsukami and C. Yuan), we will study, using high resolution
magnetic resonance imaging, a cohort of patients with moderate internal
carotid artery stenosis. We will test the hypothesis that the fibrous
caps of these lesions generally are thick and that thinning of the cap
develops after the plaque enlarges and the lumen narrows. We will also
determine whether ischemic neurological events or plaque rupture
assessed by histological evaluation of excised plaques correlates with
fibrous cap thinning. In Grant 2 (A. Clowes and M. Reidy), we will make
use of animal models to define the contribution of increased apoptosis
and matrix metalloproteinase expression to fibrous cap atrophy. We will
attempt to demonstrate in rats that luminal narrowing by a rigid wrap
models the state of an advanced human atherosclerotic internal carotid
artery and causes cell death and intimal matrix degradation, a process
that might depend upon certain secondary stress signaling pathways. In
Grant 3 (S.M. Schwartz and D. Dichek), we will define the protease
cascade leading to cell death in human lesions and correlate these
findings in operative specimens with MR evidence of cap thinning. We
will also test the hypothesis that certain fibrous caps do not rupture
because of increased expression of anti-apoptotic genes. Finally, we
will attempt to diminish or enhance the stability of fibrous caps in apo
E deficient mice by gene transfer of select pro-or anti-apoptotic genes.
These collaborative studies should provide novel insights into the basic
mechanisms underlying fibrous cap atrophy and disruption.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VASCULATA 2014
-
批准号:8785015
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2014
-
负责人:Stephen MARK Schwartz
-
依托单位:
IMMUNOGENETICS OF HPV-RELATED CANCERS
-
批准号:8307529
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2011
-
负责人:Stephen MARK Schwartz
-
依托单位:
VASCULATA V - 2008: the basic science of cardiovascular disease, including the in
-
批准号:7545808
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2008
-
负责人:Stephen MARK Schwartz
-
依托单位:
IMMUNOGENETICS OF HPV-RELATED CANCERS
-
批准号:7300322
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2007
-
负责人:Stephen MARK Schwartz
-
依托单位:
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE
-
批准号:6668562
-
项目类别:
-
资助金额:$241.34万
-
财政年份:2002
-
负责人:Stephen MARK Schwartz
-
依托单位:
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE
-
批准号:7105585
-
项目类别:
-
资助金额:$210.43万
-
财政年份:2002
-
负责人:Stephen MARK Schwartz
-
依托单位:
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE
-
批准号:6570065
-
项目类别:
-
资助金额:$202.6万
-
财政年份:2002
-
负责人:Stephen MARK Schwartz
-
依托单位:
SMOOTH MUSCLE CELL APOPTOSIS
-
批准号:6575709
-
项目类别:
-
资助金额:$6.54万
-
财政年份:2002
-
负责人:Stephen MARK Schwartz
-
依托单位:
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE
-
批准号:6793153
-
项目类别:
-
资助金额:$252.39万
-
财政年份:2002
-
负责人:Stephen MARK Schwartz
-
依托单位:
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE
-
批准号:6944351
-
项目类别:
-
资助金额:$247.14万
-
财政年份:2002
-
负责人:Stephen MARK Schwartz
-
依托单位:
Critical Role of Macrophage Death in Plaque Progression
-
批准号:6678752
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2002
-
负责人:Stephen MARK Schwartz
-
依托单位:
SMOOTH MUSCLE CELL APOPTOSIS
-
批准号:6302082
-
项目类别:
-
资助金额:$17.71万
-
财政年份:2000
-
负责人:Stephen MARK Schwartz
-
依托单位:
PROPERTIES OF THE INTIMAL SMOOTH MUSCLE CELL
-
批准号:6389652
-
项目类别:
-
资助金额:$36.55万
-
财政年份:1999
-
负责人:Stephen MARK Schwartz
-
依托单位:
SMOOTH MUSCLE CELL APOPTOSIS
-
批准号:6109237
-
项目类别:
-
资助金额:$17.71万
-
财政年份:1999
-
负责人:Stephen MARK Schwartz
-
依托单位:
PROPERTIES OF THE INTIMAL SMOOTH MUSCLE CELL
-
批准号:6537307
-
项目类别:
-
资助金额:$37.51万
-
财政年份:1999
-
负责人:Stephen MARK Schwartz
-
依托单位:
PROPERTIES OF THE INTIMAL SMOOTH MUSCLE CELL
-
批准号:2854246
-
项目类别:
-
资助金额:$33.02万
-
财政年份:1999
-
负责人:Stephen MARK Schwartz
-
依托单位:
PROPERTIES OF THE INTIMAL SMOOTH MUSCLE CELL
-
批准号:6184121
-
项目类别:
-
资助金额:$34.26万
-
财政年份:1999
-
负责人:Stephen MARK Schwartz
-
依托单位:
SMOOTH MUSCLE CELL APOPTOSIS
-
批准号:6272473
-
项目类别:
-
资助金额:$18.87万
-
财政年份:1998
-
负责人:Stephen MARK Schwartz
-
依托单位:
A MURINE MODEL FOR PLAQUE RUPTURE
-
批准号:6544889
-
项目类别:
-
资助金额:$3.12万
-
财政年份:1998
-
负责人:Stephen MARK Schwartz
-
依托单位:
MYOCARDIAL INFARCT: YOUNG WOMEN: PLASMA HOMOCYSTEINE, FOLATE, MTHFR GENE VARIANT
-
批准号:6277357
-
项目类别:
-
资助金额:$5.66万
-
财政年份:1998
-
负责人:Stephen MARK Schwartz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: